Breakthrough: Testosterone Gel Halts Age-Related Belly Fat in Hip Fracture Recovery
Breakthrough: Testosterone Gel Halts Age-Related Belly Fat in Hip Fracture Recovery
A team of scientists has discovered that a combination of testosterone gel and exercise can stop the dangerous accumulation of visceral belly fat that typically occurs with aging. The finding, published today, offers a promising new approach for improving recovery and long-term health in older adults.

In a study of women over 65 recovering from hip fractures, those who applied a daily testosterone gel and followed a structured exercise program saw no increase in visceral fat over six months, unlike a control group that gained significant abdominal fat. Visceral fat, hidden deep in the abdomen, is linked to higher risks of heart disease, diabetes, and inflammation.
“This is the first time we’ve shown that a simple intervention can prevent the unhealthy fat redistribution that accelerates with age,” said Dr. Elena Martinez, lead researcher at the University of Colorado’s Anschutz Medical Campus. “Testosterone appears to be a key regulator of where fat is stored, and our results suggest it could be harnessed to protect vulnerable patients.”
Background
Aging does more than add pounds—it fundamentally reshapes body composition. Fat shifts from subcutaneous stores under the skin to dangerous visceral depots around organs. This redistribution is especially pronounced after major trauma like a hip fracture, when immobility and hormonal changes accelerate the process.
Prior research has shown testosterone levels naturally decline with age in both men and women, contributing to muscle loss and fat gain. Until now, no study had tested whether replacing testosterone could counter the fat redistribution that complicates recovery from orthopedic injuries.
What This Means
For the 300,000 older Americans who suffer hip fractures each year, this discovery could transform rehabilitation. By preventing visceral fat buildup, the treatment may reduce the risk of metabolic diseases and improve overall outcomes. “We’re not just helping bones heal—we’re protecting the whole body from the cascade of aging,” noted Dr. Martinez.
However, experts caution that testosterone therapy requires careful medical supervision due to potential side effects, including blood clots and hormonal imbalances. The study’s authors are planning larger trials to confirm safety and effectiveness in broader populations. “This is a proof of concept, but it opens a door we’ve never had before,” added Dr. James Liu, a geriatric endocrinologist at Johns Hopkins who was not involved in the study.